PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
21-Apr-2021 Geratherm Medical AG: Stepping back Geratherm Medical AG
21-Apr-2021 Loos, France, Isovital Headquarter, Avril 21st 2021 - Radiopharma Logistics Group (RLG); Our three companies are certified again! Isovital
21-Apr-2021 Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines Nanoform Finland Plc
21-Apr-2021 Moderna Announces New Supply Agreement with Israel for 2022 Moderna
21-Apr-2021 According to the preliminary IFRS financial statements for the 2020 financial year, HAEMATO AG increased its revenue by 20.5 % to EUR 238.3 million and increased EBITDA by 74.8 % to EUR 3.3 million HAEMATO AG
21-Apr-2021 Hikma resumes launch of generic Advair Diskus Hikma Pharmaceuticals PLC
21-Apr-2021 ProQR Announces Annual Meeting of Shareholders ProQR Therapeutics N.V.
21-Apr-2021 GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex GW Pharmaceuticals
21-Apr-2021 APONTIS PHARMA plans initial public offering APONTIS PHARMA AG
21-Apr-2021 Evolva Q1 2021 Trading Update Evolva Holding SA
21-Apr-2021 Lists of candidates for the board of directors at the AGM 2021 Cassiopea S.p.A.
20-Apr-2021 ​​​​​​​Epigenomics AG announces conversion result of the first conversion period of the mandatory convertible bond 2021/2024 Epigenomics AG
20-Apr-2021 Nass Valley Gateway Ltd.: JEFF ROGERS AND TROY DOOLY WILL LEAD THE LAUNCH OF NASS VALLEY DIRECT, A NATIONWIDE CBD DIRECT SALES PLATFORM Nass Valley Gateway Ltd.
20-Apr-2021 Queen Mary University of London opens new life science business incubation space in Whitechapel Queen Mary University of London
20-Apr-2021 Astek Technology Offers Timely Electrotherapy Devices to Help People Improve Their Health At Home During the Pandemic Astek Technology
20-Apr-2021 Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy F-star Therapeutics, Inc.
20-Apr-2021 Oxitec Receives Landmark Biosafety Approval for New Fall Armyworm Control Solution Oxitec
20-Apr-2021 Mestag Therapeutics launches with seed financing of $11 million to develop therapeutics targeting activated fibroblast populations across inflammatory disease and cancer Mestag Therapeutics
20-Apr-2021 Synendos Therapeutics Expands Series A to CHF 24 million with new investment Synendos Therapeutics
20-Apr-2021 Valo Therapeutics Acquires University of Helsinki’s PeptiBAC Cancer and Infectious Disease Vaccination Technology Valo Therapeutics